National Cancer Institute

FY 2015 Research Funding by Research Topic

Cancer Type Funded Amount
Agent Orange/Dioxin Related $466,596
Aging $58,723,247
Alcoholism Research $476,258
Arctic $562,755
Arthritis $1,229,951
Ataxia Telangiectasia $1,422,191
Autoimmune Diseases $6,470,568
Basic Behavioral and Social Science $73,320,575
Behavioral and Social Science $237,783,804
Biochemical Epidemiology $206,782,732
Bioengineering $152,862,468
Bone Marrow Transplantation $43,668,333
Cancer $4,951,675,428
Cancer Survivorship $192,477,735
Cervical Cancer Education $6,291,804
Chemoprevention $109,956,921
Chemotherapy $267,914,843
Childhood Cancers $205,060,620
Chronic Myeloproliferative Disorders $32,556,862
Contraception and Reproduction Research $1,497,781
Depression Research $11,390,662
Diabetes $12,438,257
Digestive Diseases $470,961,767
Down Syndrome $1,205,792
Gene Therapy $39,508,420
Gene Therapy Clinical Trials $8,320,678
Genetic Testing $40,991,373
Herpes - Genital $96,963
Herpes - Other $44,620,533
Inflammatory Bowel Disease $2,256,621
Interferon $3,812,830
Metastasis $384,561,391
Neurofibromatosis $6,452,887
Nuclear Magnetic Resonance Imaging (NMR) $94,774,418
Nursing Oncology $15,688,693
Organ Transplantation Research $48,711,965
Pesticides $2,271,180
Sleep Disorders $7,853,473
Smoking Behavior $65,101,033
Surgery $54,155,522
Taxol $15,468,676
Tuberous Sclerosis $2,660,920